Specificity and mechanism of error-prone replication by human immunodeficiency virus-1 reverse transcriptase.

PubWeight™: 3.80‹?› | Rank: Top 1%

🔗 View Article (PMID 2476448)

Published in J Biol Chem on October 05, 1989

Authors

K Bebenek1, J Abbotts, J D Roberts, S H Wilson, T A Kunkel

Author Affiliations

1: Laboratory of Molecular Genetics, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina 27709.

Articles citing this

Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase. J Virol (1995) 9.02

Replication-competent noninduced proviruses in the latent reservoir increase barrier to HIV-1 cure. Cell (2013) 6.47

Selection, recombination, and G----A hypermutation of human immunodeficiency virus type 1 genomes. J Virol (1991) 5.03

Broad spectrum of in vivo forward mutations, hypermutations, and mutational hotspots in a retroviral shuttle vector after a single replication cycle: substitutions, frameshifts, and hypermutations. Proc Natl Acad Sci U S A (1990) 4.72

High fidelity DNA synthesis by the Thermus aquaticus DNA polymerase. Nucleic Acids Res (1990) 4.12

Retrovirus variation and reverse transcription: abnormal strand transfers result in retrovirus genetic variation. Proc Natl Acad Sci U S A (1993) 4.04

Reduced replication of 3TC-resistant HIV-1 variants in primary cells due to a processivity defect of the reverse transcriptase enzyme. EMBO J (1996) 3.92

Viral mutation rates. J Virol (2010) 3.87

Human immunodeficiency virus type 1 DNA sequences genetically damaged by hypermutation are often abundant in patient peripheral blood mononuclear cells and may be generated during near-simultaneous infection and activation of CD4(+) T cells. J Virol (2001) 2.89

Reverse transcriptases and genomic variability: the accuracy of DNA replication is enzyme specific and sequence dependent. EMBO J (1990) 2.64

Human immunodeficiency virus type 1 recombination: rate, fidelity, and putative hot spots. J Virol (2002) 2.50

Marked infidelity of human immunodeficiency virus type 1 reverse transcriptase at RNA and DNA template ends. Proc Natl Acad Sci U S A (1994) 2.12

Unusual polymorphisms in human immunodeficiency virus type 1 associated with nonprogressive infection. J Virol (2000) 2.04

5-Azacytidine and RNA secondary structure increase the retrovirus mutation rate. J Virol (1992) 2.03

Unequal human immunodeficiency virus type 1 reverse transcriptase error rates with RNA and DNA templates. Proc Natl Acad Sci U S A (1992) 1.93

Analysis of long terminal repeat circle junctions of human immunodeficiency virus type 1. J Virol (1990) 1.80

Nature, position, and frequency of mutations made in a single cycle of HIV-1 replication. J Virol (2010) 1.65

Genetic rearrangements occurring during a single cycle of murine leukemia virus vector replication: characterization and implications. J Virol (1995) 1.62

APOBEC3G contributes to HIV-1 variation through sublethal mutagenesis. J Virol (2010) 1.58

Error-prone replication of repeated DNA sequences by T7 DNA polymerase in the absence of its processivity subunit. Proc Natl Acad Sci U S A (1994) 1.51

Replication infidelity during a single cycle of Ty1 retrotransposition. Proc Natl Acad Sci U S A (1996) 1.45

Pausing of reverse transcriptase on retroviral RNA templates is influenced by secondary structures both 5' and 3' of the catalytic site. Nucleic Acids Res (1998) 1.43

Deoxyribonucleoside triphosphate pool imbalances in vivo are associated with an increased retroviral mutation rate. J Virol (1998) 1.40

Evolution of the human immunodeficiency virus type 1 envelope during infection reveals molecular corollaries of specificity for coreceptor utilization and AIDS pathogenesis. J Virol (2000) 1.39

Too many mutants with multiple mutations. Crit Rev Biochem Mol Biol (2007) 1.38

Clusters of mutations from transient hypermutability. Proc Natl Acad Sci U S A (2005) 1.35

Modification of retroviral RNA by double-stranded RNA adenosine deaminase. J Virol (1995) 1.31

3'-Azido-3'-deoxythymidine (AZT) and AZT-resistant reverse transcriptase can increase the in vivo mutation rate of human immunodeficiency virus type 1. J Virol (2000) 1.26

The influence of 3TC resistance mutation M184I on the fidelity and error specificity of human immunodeficiency virus type 1 reverse transcriptase. Nucleic Acids Res (1998) 1.24

Rapid evolution of HIV-1 to functional CD8⁺ T cell responses in humanized BLT mice. Sci Transl Med (2012) 1.21

Differential DNA secondary structure-mediated deletion mutation in the leading and lagging strands. J Bacteriol (1995) 1.19

Mutation rates and intrinsic fidelity of retroviral reverse transcriptases. Viruses (2009) 1.19

Increased misincorporation fidelity observed for nucleoside analog resistance mutations M184V and E89G in human immunodeficiency virus type 1 reverse transcriptase does not correlate with the overall error rate measured in vitro. J Virol (1998) 1.19

In vivo analysis of human T-cell leukemia virus type 1 reverse transcription accuracy. J Virol (2000) 1.18

Low-cost ultra-wide genotyping using Roche/454 pyrosequencing for surveillance of HIV drug resistance. PLoS One (2012) 1.18

The antiretrovirus drug 3'-azido-3'-deoxythymidine increases the retrovirus mutation rate. J Virol (1997) 1.16

Fidelity of DNA synthesis catalyzed by human DNA polymerase alpha and HIV-1 reverse transcriptase: effect of reaction pH. Nucleic Acids Res (1993) 1.15

Retroviral mutation rates and A-to-G hypermutations during different stages of retroviral replication. J Virol (1996) 1.14

Conserved subfamilies of the Drosophila HeT-A telomere-specific retrotransposon. Genetics (1998) 1.13

Herpes simplex virus type 2 glycoprotein G-negative clinical isolates are generated by single frameshift mutations. J Virol (1999) 1.13

Mutagenicity and pausing of HIV reverse transcriptase during HIV plus-strand DNA synthesis. Nucleic Acids Res (1994) 1.13

High rates of frameshift mutations within homo-oligomeric runs during a single cycle of retroviral replication. J Virol (1994) 1.12

Mechanistic differences in RNA-dependent DNA polymerization and fidelity between murine leukemia virus and HIV-1 reverse transcriptases. J Biol Chem (2005) 1.10

Higher fidelity of RNA-dependent DNA mispair extension by M184V drug-resistant than wild-type reverse transcriptase of human immunodeficiency virus type 1. Nucleic Acids Res (1997) 1.10

Human immunodeficiency viruses containing heterologous enhancer/promoters are replication competent and exhibit different lymphocyte tropisms. J Virol (1993) 1.10

In vitro priming recapitulates in vivo HIV-1 specific T cell responses, revealing rapid loss of virus reactive CD4 T cells in acute HIV-1 infection. PLoS One (2009) 1.09

Increased polymerase fidelity of E89G, a nucleoside analog-resistant variant of human immunodeficiency virus type 1 reverse transcriptase. J Virol (1996) 1.09

Secondary structure model of the Mason-Pfizer monkey virus 5' leader sequence: identification of a structural motif common to a variety of retroviruses. J Virol (1995) 1.09

Human immunodeficiency virus reverse transcriptase displays dramatically higher fidelity under physiological magnesium conditions in vitro. J Virol (2014) 1.09

The impact of multidideoxynucleoside resistance-conferring mutations in human immunodeficiency virus type 1 reverse transcriptase on polymerase fidelity and error specificity. J Virol (1998) 1.08

Unselected mutations in the human immunodeficiency virus type 1 genome are mostly nonsynonymous and often deleterious. J Virol (2004) 1.05

A template-dependent dislocation mechanism potentiates K65R reverse transcriptase mutation development in subtype C variants of HIV-1. PLoS One (2011) 1.04

Efficient extension of a misaligned tRNA-primer during replication of the HIV-1 retrovirus. Nucleic Acids Res (1995) 1.03

In-depth, longitudinal analysis of viral quasispecies from an individual triply infected with late-stage human immunodeficiency virus type 1, using a multiple PCR primer approach. J Virol (2005) 1.03

Biochemical characterization of enzyme fidelity of influenza A virus RNA polymerase complex. PLoS One (2010) 1.00

Effects of amino acid substitutions at position 115 on the fidelity of human immunodeficiency virus type 1 reverse transcriptase. J Virol (2000) 0.99

Lamivudine can exert a modest antiviral effect against human immunodeficiency virus type 1 containing the M184V mutation. Antimicrob Agents Chemother (2003) 0.99

Mutation spectra of herpes simplex virus type 1 thymidine kinase mutants. J Virol (2002) 0.98

A DNA polymerase alpha pause site is a hot spot for nucleotide misinsertion. Proc Natl Acad Sci U S A (1992) 0.97

Development of an in vivo assay to identify structural determinants in murine leukemia virus reverse transcriptase important for fidelity. J Virol (2000) 0.97

Effect of reaction conditions and 3AB on the mutation rate of poliovirus RNA-dependent RNA polymerase in a alpha-complementation assay. Virus Res (2009) 0.96

Characterizing and mapping porcine endogenous retroviruses in Westran pigs. J Virol (2002) 0.94

Small RNA expression profiling by high-throughput sequencing: implications of enzymatic manipulation. J Nucleic Acids (2012) 0.94

Mutagenesis by metal-induced oxygen radicals. Environ Health Perspect (1994) 0.94

In vitro fidelity of the prototype primate foamy virus (PFV) RT compared to HIV-1 RT. Virology (2007) 0.93

Stable complexes formed by HIV-1 reverse transcriptase at distinct positions on the primer-template controlled by binding deoxynucleoside triphosphates or foscarnet. J Mol Biol (2007) 0.93

Site-directed mutagenesis in the fingers subdomain of HIV-1 reverse transcriptase reveals a specific role for the beta3-beta4 hairpin loop in dNTP selection. J Mol Biol (2006) 0.92

Error-prone retrotransposition: rime of the ancient mutators. Proc Natl Acad Sci U S A (1996) 0.91

Single-stranded DNA-binding protein enhances the stability of CTG triplet repeats in Escherichia coli. J Bacteriol (1996) 0.90

The external domains of the HIV-1 envelope are a mutational cold spot. Nat Commun (2015) 0.89

Human immunodeficiency virus mutagenesis during antiviral therapy: impact of drug-resistant reverse transcriptase and nucleoside and nonnucleoside reverse transcriptase inhibitors on human immunodeficiency virus type 1 mutation frequencies. J Virol (2005) 0.89

Nucleotide modification at the gamma-phosphate leads to the improved fidelity of HIV-1 reverse transcriptase. Nucleic Acids Res (2005) 0.89

Defective virus drives human immunodeficiency virus infection, persistence, and pathogenesis. Clin Vaccine Immunol (2006) 0.89

Naturally occurring accessory gene mutations lead to persistent human immunodeficiency virus type 1 infection of CD4-positive T cells. J Virol (1995) 0.88

The reverse transcriptase encoded by the non-LTR retrotransposon R2 is as error-prone as that encoded by HIV-1. J Mol Biol (2011) 0.87

Importance of purine and pyrimidine content of local nucleotide sequences (six bases long) for evolution of the human immunodeficiency virus type 1. Proc Natl Acad Sci U S A (1991) 0.87

Frequent polymerase errors observed in a restricted area of clones derived from the attachment (G) protein gene of respiratory syncytial virus. J Virol (1993) 0.87

Strand transfer is enhanced by mismatched nucleotides at the 3' primer terminus: a possible link between HIV reverse transcriptase fidelity and recombination. Nucleic Acids Res (1996) 0.84

Probing the active site steric flexibility of HIV-1 reverse transcriptase: different constraints for DNA- versus RNA-templated synthesis. Biochemistry (2008) 0.83

Natural epitope variants of the hepatitis C virus impair cytotoxic T lymphocyte activity. World J Gastroenterol (2010) 0.82

Reiterative dG addition by Euplotes crassus telomerase during extension of non-telomeric DNA. Nucleic Acids Res (1998) 0.82

Size variation within the second hypervariable region of the surface envelope gene of the bovine lentivirus BIV in experimentally and naturally infected cattle. J Virol (1997) 0.82

4'-Acylated thymidine 5'-triphosphates: a tool to increase selectivity towards HIV-1 reverse transcriptase. Nucleic Acids Res (1998) 0.81

A screen in Escherichia coli for nucleoside analogs that target human immunodeficiency virus (HIV) reverse transcriptase: coexpression of HIV reverse transcriptase and herpes simplex virus thymidine kinase. J Virol (1995) 0.81

Fidelity of reverse transcriptase of the simian immunodeficiency virus from African green monkey. Nucleic Acids Res (1991) 0.80

Utilization of a deoxynucleoside diphosphate substrate by HIV reverse transcriptase. PLoS One (2008) 0.80

Altered error specificity of RNase H-deficient HIV-1 reverse transcriptases during DNA-dependent DNA synthesis. Nucleic Acids Res (2013) 0.80

Gene therapy targeting HIV entry. Viruses (2014) 0.79

Silent mutations at codons 65 and 66 in reverse transcriptase alleviate indel formation and restore fitness in subtype B HIV-1 containing D67N and K70R drug resistance mutations. Nucleic Acids Res (2015) 0.79

Mismatched nucleotides may facilitate expansion of trinucleotide repeats in genetic diseases. Nucleic Acids Res (1998) 0.78

Mutations in HIV-1 reverse transcriptase affect the errors made in a single cycle of viral replication. J Virol (2014) 0.78

Expression of mutated Paramecium telomerase RNAs in vivo leads to templating errors that resemble those made by retroviral reverse transcriptase. Mol Cell Biol (1999) 0.77

Differences in mutagenesis during minus strand, plus strand and strand transfer (recombination) synthesis of the HIV-1 gene in vitro. Nucleic Acids Res (1996) 0.77

Retroviral vectors for analysis of viral mutagenesis and recombination. Viruses (2014) 0.76

Intrinsic DNA synthesis fidelity of xenotropic murine leukemia virus-related virus reverse transcriptase. FEBS J (2012) 0.76

Resolution of Specific Nucleotide Mismatches by Wild-Type and AZT-Resistant Reverse Transcriptases during HIV-1 Replication. J Mol Biol (2016) 0.75

Analysis of selection pressure and mutational pattern of HIV type 1 reverse transcriptase region among treated and nontreated patients. AIDS Res Hum Retroviruses (2010) 0.75

Resistance evolution in HIV - modeling when to intervene. Proc Am Control Conf (2012) 0.75

Articles by these authors

Rapid and efficient site-specific mutagenesis without phenotypic selection. Proc Natl Acad Sci U S A (1985) 68.48

Rapid and efficient site-specific mutagenesis without phenotypic selection. Methods Enzymol (1987) 66.52

Fidelity of DNA synthesis by the Thermus aquaticus DNA polymerase. Biochemistry (1988) 9.66

Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. Proc Natl Acad Sci U S A (1998) 9.66

The accuracy of reverse transcriptase from HIV-1. Science (1988) 8.24

Efficient site-directed mutagenesis using uracil-containing DNA. Methods Enzymol (1991) 7.94

Fidelity of DNA synthesis. Annu Rev Biochem (1982) 6.54

Mutational specificity of depurination. Proc Natl Acad Sci U S A (1984) 6.51

The Y-family of DNA polymerases. Mol Cell (2001) 6.49

Structures of ternary complexes of rat DNA polymerase beta, a DNA template-primer, and ddCTP. Science (1994) 5.57

Requirement of mammalian DNA polymerase-beta in base-excision repair. Nature (1996) 4.95

Crystal structures of human DNA polymerase beta complexed with gapped and nicked DNA: evidence for an induced fit mechanism. Biochemistry (1997) 4.55

Requirement for PCNA in DNA mismatch repair at a step preceding DNA resynthesis. Cell (1996) 4.47

Predicted normal values for maximal respiratory pressures in caucasian adults and children. Thorax (1984) 4.42

DNA polymerase fidelity and the polymerase chain reaction. PCR Methods Appl (1991) 4.31

The base substitution fidelity of eucaryotic DNA polymerases. Mispairing frequencies, site preferences, insertion preferences, and base substitution by dislocation. J Biol Chem (1986) 4.25

Deoxynucleoside [1-thio]triphosphates prevent proofreading during in vitro DNA synthesis. Proc Natl Acad Sci U S A (1981) 4.14

High fidelity DNA synthesis by the Thermus aquaticus DNA polymerase. Nucleic Acids Res (1990) 4.12

Crystal structure of rat DNA polymerase beta: evidence for a common polymerase mechanism. Science (1994) 4.11

Nuclear magnetic resonance spectroscopy. Benzene-13C. J Am Chem Soc (1967) 4.07

The mutational specificity of DNA polymerase-beta during in vitro DNA synthesis. Production of frameshift, base substitution, and deletion mutations. J Biol Chem (1985) 3.98

Aromatic hydrogen bond in sequence-specific protein DNA recognition. Nat Struct Biol (1996) 3.91

Cell type and pathway dependence of synaptic AMPA receptor number and variability in the hippocampus. Neuron (1998) 3.90

Glutamatergic synapses on oligodendrocyte precursor cells in the hippocampus. Nature (2000) 3.70

Human chromosome 3 corrects mismatch repair deficiency and microsatellite instability and reduces N-methyl-N'-nitro-N-nitrosoguanidine tolerance in colon tumor cells with homozygous hMLH1 mutation. Cancer Res (1994) 3.63

Somatic mutation hotspots correlate with DNA polymerase eta error spectrum. Nat Immunol (2001) 3.60

A sensitive genetic assay for the detection of cytosine deamination: determination of rate constants and the activation energy. Biochemistry (1990) 3.51

Eukaryotic DNA polymerase amino acid sequence required for 3'----5' exonuclease activity. Proc Natl Acad Sci U S A (1991) 3.44

Structure of rodent helix-destabilizing protein revealed by cDNA cloning. J Biol Chem (1986) 3.28

Perisynaptic location of metabotropic glutamate receptors mGluR1 and mGluR5 on dendrites and dendritic spines in the rat hippocampus. Eur J Neurosci (1996) 3.22

Phenylalanines that are conserved among several RNA-binding proteins form part of a nucleic acid-binding pocket in the A1 heterogeneous nuclear ribonucleoprotein. J Biol Chem (1988) 3.16

Heteroduplex repair in extracts of human HeLa cells. J Biol Chem (1991) 3.13

Natural-abundance C nuclear magnetic resonance spectra of medium-molecular-weight organic compounds. Proc Natl Acad Sci U S A (1968) 3.11

Fidelity of two retroviral reverse transcriptases during DNA-dependent DNA synthesis in vitro. Mol Cell Biol (1989) 3.00

Infidelity of DNA synthesis associated with bypass of apurinic sites. Proc Natl Acad Sci U S A (1983) 2.95

Mammalian heterogeneous nuclear ribonucleoprotein complex protein A1. Large-scale overproduction in Escherichia coli and cooperative binding to single-stranded nucleic acids. J Biol Chem (1988) 2.88

The lyase activity of the DNA repair protein beta-polymerase protects from DNA-damage-induced cytotoxicity. Nature (2000) 2.88

Low fidelity DNA synthesis by human DNA polymerase-eta. Nature (2000) 2.85

Defective mismatch repair in extracts of colorectal and endometrial cancer cell lines exhibiting microsatellite instability. J Biol Chem (1994) 2.82

Specialized nucleoprotein structures at the origin of replication of bacteriophage lambda: localized unwinding of duplex DNA by a six-protein reaction. Proc Natl Acad Sci U S A (1986) 2.79

The metabotropic glutamate receptor (mGluR1 alpha) is concentrated at perisynaptic membrane of neuronal subpopulations as detected by immunogold reaction. Neuron (1993) 2.75

The mutational specificity of DNA polymerases-alpha and -gamma during in vitro DNA synthesis. J Biol Chem (1985) 2.66

Passing the baton in base excision repair. Nat Struct Biol (2000) 2.65

Nucleotide repeats. Slippery DNA and diseases. Nature (1993) 2.56

Analyzing fidelity of DNA polymerases. Methods Enzymol (1995) 2.52

Mammalian abasic site base excision repair. Identification of the reaction sequence and rate-determining steps. J Biol Chem (1998) 2.49

DNA polymerase beta conducts the gap-filling step in uracil-initiated base excision repair in a bovine testis nuclear extract. J Biol Chem (1995) 2.42

Frameshift mutagenesis by eucaryotic DNA polymerases in vitro. J Biol Chem (1986) 2.40

Depurination-induced infidelity of deoxyribonucleic acid synthesis with purified deoxyribonucleic acid replication proteins in vitro. Biochemistry (1983) 2.38

The fidelity of DNA synthesis catalyzed by derivatives of Escherichia coli DNA polymerase I. J Biol Chem (1990) 2.36

Microsatellite instability, mismatch repair deficiency, and genetic defects in human cancer cell lines. Cancer Res (1995) 2.35

Initiation of bacteriophage lambda DNA replication in vitro with purified lambda replication proteins. Proc Natl Acad Sci U S A (1982) 2.31

Cell surface domain specific postsynaptic currents evoked by identified GABAergic neurones in rat hippocampus in vitro. J Physiol (2000) 2.28

Mutator phenotypes conferred by MLH1 overexpression and by heterozygosity for mlh1 mutations. Mol Cell Biol (1999) 2.26

Crystal structures of human DNA polymerase beta complexed with DNA: implications for catalytic mechanism, processivity, and fidelity. Biochemistry (1996) 2.25

Transplacental transmission of natural-killer-cell lymphoma. N Engl J Med (1999) 2.23

HTLV-I trans-activator protein, tax, is a trans-repressor of the human beta-polymerase gene. Science (1990) 2.23

Human DNA polymerase beta deoxyribose phosphate lyase. Substrate specificity and catalytic mechanism. J Biol Chem (1998) 2.21

On the fidelity of DNA replication. Effect of divalent metal ion activators and deoxyrionucleoside triphosphate pools on in vitro mutagenesis. J Biol Chem (1979) 2.20

DNA loop repair by human cell extracts. Science (1994) 2.19

Evidence for a connection between the mismatch repair system and the G2 cell cycle checkpoint. Cancer Res (1995) 2.17

Fidelity of mammalian DNA polymerases. Science (1981) 2.17

The 3'-->5' exonuclease of DNA polymerase delta can substitute for the 5' flap endonuclease Rad27/Fen1 in processing Okazaki fragments and preventing genome instability. Proc Natl Acad Sci U S A (2001) 2.16

Specific interaction of DNA polymerase beta and DNA ligase I in a multiprotein base excision repair complex from bovine testis. J Biol Chem (1996) 2.10

Fidelity and processivity of DNA synthesis by DNA polymerase kappa, the product of the human DINB1 gene. J Biol Chem (2000) 2.06

Purification and characterization of DNA polymerase II from the yeast Saccharomyces cerevisiae. Identification of the catalytic core and a possible holoenzyme form of the enzyme. J Biol Chem (1990) 2.06

Error-prone polymerization by HIV-1 reverse transcriptase. Contribution of template-primer misalignment, miscoding, and termination probability to mutational hot spots. J Biol Chem (1993) 2.04

Expression of human DNA polymerase beta in Escherichia coli and characterization of the recombinant enzyme. Biochemistry (1988) 2.02

Nitrogen-15 nuclear magnetic resonance spectroscopy of some nucleosides and nucleotides. J Am Chem Soc (1977) 2.02

Mutagenesis in vitro by DNA polymerase from an RNA tumour virus. Nature (1979) 2.00

Purification and domain-mapping of mammalian DNA polymerase beta. Methods Enzymol (1995) 2.00

Functional interaction of proliferating cell nuclear antigen with MSH2-MSH6 and MSH2-MSH3 complexes. J Biol Chem (2000) 1.99

Evidence that errors made by DNA polymerase alpha are corrected by DNA polymerase delta. Curr Biol (2006) 1.98

Correction of hypermutability, N-methyl-N'-nitro-N-nitrosoguanidine resistance, and defective DNA mismatch repair by introducing chromosome 2 into human tumor cells with mutations in MSH2 and MSH6. Cancer Res (1997) 1.96

Short gap-filling synthesis by DNA polymerase beta is processive. J Biol Chem (1993) 1.95

A novel DNA polymerase activity found in association with intracisternal A-type particles. Proc Natl Acad Sci U S A (1972) 1.94

Identification of an intrinsic 5'-deoxyribose-5-phosphate lyase activity in human DNA polymerase lambda: a possible role in base excision repair. J Biol Chem (2001) 1.94

Unequal human immunodeficiency virus type 1 reverse transcriptase error rates with RNA and DNA templates. Proc Natl Acad Sci U S A (1992) 1.93

Impairment of proliferating cell nuclear antigen-dependent apurinic/apyrimidinic site repair on linear DNA. J Biol Chem (1998) 1.93

The fidelity of human DNA polymerase gamma with and without exonucleolytic proofreading and the p55 accessory subunit. J Biol Chem (2001) 1.92

DNA structure and aspartate 276 influence nucleotide binding to human DNA polymerase beta. Implication for the identity of the rate-limiting conformational change. J Biol Chem (2000) 1.87

Altered spectra of hypermutation in antibodies from mice deficient for the DNA mismatch repair protein PMS2. Proc Natl Acad Sci U S A (1998) 1.86

International Commission for Protection Against Environmental Mutagens and Carcinogens. Deoxyribonucleoside triphosphate levels: a critical factor in the maintenance of genetic stability. Mutat Res (1994) 1.86

NMDA receptor content of synapses in stratum radiatum of the hippocampal CA1 area. J Neurosci (2000) 1.86

Error rate and specificity of human and murine DNA polymerase eta. J Mol Biol (2001) 1.86

The effects of dNTP pool imbalances on frameshift fidelity during DNA replication. J Biol Chem (1992) 1.85

Enzyme-DNA interactions required for efficient nucleotide incorporation and discrimination in human DNA polymerase beta. J Biol Chem (1996) 1.85

Abasic translesion synthesis by DNA polymerase beta violates the "A-rule". Novel types of nucleotide incorporation by human DNA polymerase beta at an abasic lesion in different sequence contexts. J Biol Chem (1997) 1.83

Studies on the mechanism of human immunodeficiency virus reverse transcriptase. Steady-state kinetics, processivity, and polynucleotide inhibition. J Biol Chem (1988) 1.82